🇮🇳IN
Sign In
SU

SUVEN

NSE

Suven Life Sciences Ltd

₹261.35

-6.85(-2.55%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

SUVEN financial summary

For Mar 2026, Suven Life Sciences Ltd reported revenue of ₹7 crore, which grew 0.0% from the previous year. Net profit was -₹55 crore, on an operating margin of -885%. Earnings per share came in at -₹2.08. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.

Revenue₹7 crore
Net profit-₹55 crore
Operating margin-885%
EPS-₹2.08

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer